¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nuclear paralysis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • general paralysis
    Àü½Å¸¶ºñ
  • hypnopompic paralysis
    Ãâ¸é¸¶ºñ, °¢¸é¸¶ºñ
  • hypokalemic paralysis
    ÀúÄ®·ýÁֱ⸶ºñ
  • hypokalemic periodic paralysis
    ÀúÄ®·ýÁֱ⸶ºñ
  • hysterical paralysis
    È÷½ºÅ׸®¸¶ºñ
  • ischemic paralysis
    ÇãÇ÷¸¶ºñ
  • isolated paralysis
    ±¹ÇѸ¶ºñ
  • infantile paralysis
    ¿µ¾Æ¸¶ºñ
  • idiopathic facial paralysis
    Ư¹ß¾ó±¼¸¶ºñ
  • lateral conjugate paralysis
    °¡ÂÊÁֽø¶ºñ, ¿ÜÃøÁֽø¶ºñ
  • motor paralysis
    ¿îµ¿¸¶ºñ
  • muscular paralysis
    ±Ù(À°)¸¶ºñ
  • musculospiral paralysis
    ³ë½Å°æ¸¶ºñ, ¿ä°ñ½Å°æ¸¶ºñ
  • myopathic paralysis
    ±Ù(À°)º´Áõ¸¶ºñ
  • nocturnal paralysis
    ¾ß°£¸¶ºñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • epidemic infantile paralysis
    À¯Çà¼Ò¾Æ¸¶ºñ
  • facial paralysis
    ¾ó±¼¸¶ºñ
  • flaccid paralysis
    À̿ϸ¶ºñ
  • general paralysis
    Àü½Å¸¶ºñ
  • hypnopompic paralysis
    Ãâ¸é¸¶ºñ, °¢¸é¸¶ºñ
  • hypokalemic paralysis
    ÀúÄ®·ý¸¶ºñ
  • hysterical paralysis
    È÷½ºÅ׸®¸¶ºñ
  • idiopathic facial paralysis
    Ư¹ß¾ó±¼¸¶ºñ
  • infantile paralysis
    ¿µ¾Æ¸¶ºñ
  • ischemic paralysis
    ÇãÇ÷¸¶ºñ
  • isolated paralysis
    ±¹ÇѸ¶ºñ
  • lateral conjugate paralysis
    °¡ÂÊÁֽø¶ºñ
  • motor paralysis
    ¿îµ¿¸¶ºñ
  • muscular paralysis
    ±ÙÀ°¸¶ºñ
  • myopathic paralysis
    ±ÙÀ°º´Áõ¸¶ºñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • postexcitatory paralysis
    ÈïºÐÈĸ¶ºñ(ýéÝÇý­Ø«Ýö)
  • progressive facial paralysis
    ÁøÇà(¼º) ¾È¸é¸¶ºñ
  • progressive spastic spinal paralysis
    ÁøÇ༺ °æ¼º ô¼ö¸¶ºñ(òäú¼àõÌâàõô±âÐ Ýö).
  • progressive spastic spinal paralysis
    ÁøÇ༺ °æ¼º ô¼ö¸¶ºñ(òäú¼àõ Ìâàõ ô±âÐØ¦Ýö)
  • prosopoplegia =facial paralysis
    ¾È¸é¸¶ºñ(äÔØüØ«Ýö)
  • prosopoplegia [=facial paralysis]
    ¾È¸é¸¶ºñ
  • pseudolaryngeal paralysis
    °¡(¼º)Èĵθ¶ºñ
  • radicular paralysis
    ±Ù(¼º)¸¶ºñ(ÐÆàõئÝö).
  • radicular paralysis
    ±Ù(¼º)¸¶ºñ(ÐÆ(àõ)ئÝö)
  • radicular paralysis
    ½Å°æ±Ù¸¶ºñ
  • recurrent nerve paralysis
    ȸ±Í½Å°æ¸¶ºñ(üÞÏýãêÌè Ýö).
  • recurrent nerve paralysis
    ȸ±Í½Å°æ¸¶ºñ(üÞÏýãêÌèØ«Ýö)
  • reflectoric paralysis of pupils
    ¹Ý»ç¼º µ¿°ø°­Á÷(ÚãÞÒàõÔÚÍî˧òÁ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • nuclear magnetic resonance
    ¹æ»ç (ÇÙÀÇ)ÇÙÀÚ±â°ø¸í.
  • nuclear magnetic resonance (NMR)
    ÇÙÀÚ±â°ø¸í
  • nuclear medicine
    ÇÙÀÇÇÐ(ú·ì¢ùÊ).
  • nuclear membrane
    ÇÙ¸·(ú·Ø¯).
  • nuclear membrane
    ÇÙ¸·
  • nuclear model
    (¿øÀÚ)ÇÙ¸ðÇü(ê«í­ú·Ù¼úþ).
  • nuclear myopia
    ¼öÁ¤Ã¼ÇٱٽÃ
  • nuclear ophthalmoplegia
    ÇÙ¼º¾È±Ù¸¶ºñ(~äÑÐÉ Ýö).
  • nuclear palsy
    ÇÙ¼º¸¶ºñ
  • nuclear paramagnetic resonance
    ÇÙ »óÀÚ¼º °ø¸í
  • nuclear paramagnetism
    ÇÙ »óÀÚ¼º
  • nuclear phenomena
    ÇÙÇö»ó
  • nuclear physics
    ÇÙ¹°¸®ÇÐ.
  • nuclear polyhedrosis virus
    ÇÙ Æú¸®Çìµå·ÐÇü¼º ¹ÙÀÌ·¯½º
  • nuclear pore
    ÇÙ°ø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PIP paralytic infantile paralysis; peak inflation pressure, peak inspiratory pressure; periodic interim ...
RFP recurrent facial paralysis; request for proposal; right frontoposterior [fetal position]
ANA Anti-Nuclear Antibody
Anti-ENA Anti-Extractable Nuclear Antigens
EBNA Epstain-Barr Nuclear Antigen
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ARNT AHR nuclear translocator protein
Arnt Ah recceptor nuclear translocator
ANA Anti-nuclear
ANA Anti-nuclear antibodies
ANA Anti-nuclear antibody
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • functional paralysis
    ±â´É¼º ¸¶ºñ
    ºÐ¸íÇÑ ½Å°æ¼º º´º¯¿¡ ±âÀÎÇÏÁö ¾Ê´Â ÀϽÃÀû ¸¶ºñ.
  • hereditary cerebrospinal paralysis
    ¿ìÀü¼º ³úô¼ö ¸¶ºñ
    º¸Åë Áß³â Ãʱ⿡ ÁøÇàÇÏ´Â À¯Àü¼º ÁúȯÀ¸·Î »óÁö ¶Ç´Â ÇÏÁöÀÇ ¾çÁö ¶Ç´Â ÀÏÃøÀ̳ª »çÁö¿¡ ³ªÅ¸³ª¸ç, ¼­¼­È÷ ÁøÇàµÇ´Â ¸¶ºñ°¡ Ư¡ÀÌ´Ù.
  • hyperkalemic periodic paralysis
    °úÄ®·ý¼º ÁÖ±âÀû ¸¶ºñ
  • hypoglssal paralysis
    ¼³ÇÏ ½Å°æ ¸¶ºñ
    ¼³ÇÏ ½Å°æ ÇÙ ¶Ç´Â ¼³ÇÏ ½Å°æ ÀϺÎÀÇ º´º¯¿¡ ÀÇÇÑ ¸¶ºñ.
  • hypokalemic paralysis
    ÀúÄ®·ýÇ÷¼º ¸¶ºñ
  • immunological paralysis
    ¸é¿ª ¸¶ºñ, ¸é¿ª °ü¿ë
    ´Ù·®ÀÇ Ç׿ø Åõ¿©¿¡ ÀÇÇÏ¿© ¸é¿ªÇÐÀû ¹ÝÀÀÀÌ ¼Ò½ÇµÈ »óÅÂ.
  • infantile cerebrocerebellar diplegic paralysis
    ¼Ò¾Æ³ú¼º ¾çÃø ¸¶ºñ
    ¿µ¾Æ±â¿¡ ÁøÇàÇÏ¿© »çÁö¸¦ ¸ðµÎ ħ¹üÇÏ¿©, ´ë³ú¿Í ¼Ò³úÀÇ »ó¹ÝµÇ´Â ºÎºÐÀÇ ¹ßÀ°ºÎÀüÀ̳ª ÆÄ±«ÀÇ È¥ÇÕÀ¸·Î ³ªÅ¸³­´Ù.
  • infantile paralysis
    ¼Ò¾Æ ¸¶ºñ, ¼Ò¾Æ³ú¼º ¿îµ¿ ½ÇÁ¶¼º ¸¶ºñ
    µ¿ÀǾî=
  • ischemic paralysis
    ÇãÇ÷¼º ¸¶ºñ
    Àü»öÁõÀ̳ª Ç÷ÀüÁõ¿¡¼­¿Í °°ÀÌ ¼øÈ¯ÀÇ °¨¼Ò¿¡ ÀÇÇÑ ±¹¼ÒÀû ¸¶ºñ.
  • Jamaica dogwood Çǽº½Ãµð¾ÆÀÇ »Ñ¸®ÀÇ ¿ø·á ½Ä¹°.

    Jamaica ginger paralysis

    ÀÚ¸¶ÀÌÄ« »ý°­ Áßµ¶¼º ¸¶ºñ
    »çÁö, ƯÈ÷ ÇÏÁöÀÇ ¸¶ºñ·Î¼­ ÀÚ¸¶ÀÌÄ« »ý°­À» À½·á¼ö·Î »ç¿ëÇßÀ» ¶§ ³ªÅ¸³­´Ù.
  • laryngeal paralysis
    ÈĵΠ¸¶ºñ
    ÇÑ ÈĵαÙÀÇ ¸¶ºñ.
  • lateral conjugate paralysis
    Ãø¹æ ½Ã ¸¶ºñ
  • lingula paralysis
    ¼³ ¹Ì°¢ ¸¶ºñ
  • masticatory paralysis
    ÀúÀÛ±Ù ¸¶ºñ
  • mixed paralysis
    È¥ÇÕ ¸¶ºñ
    ¿îµ¿°ú °¨°¢ÀÇ ¿¬ÇÕ ¸¶ºñ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
nuclear medicine department, hospital Hospital department responsible for the administration and management of nuclear medicine services.
(12 Dec 1998)
nuclear medicine physician <specialist> A specialist trained in the interpretation and administration of diagnostic tests that use radionuclide compounds.
(27 Sep 1997)
nuclear membrane An intracellular structure, consisting of two concentric membranes, enclosing the nucleoplasm and separating it from the cytoplasm. The areas where these two membranes fuse are called nuclear pore complexes.
(12 Dec 1998)
nuclear ophthalmoplegia Ophthalmoplegia due to a lesion of the nuclei of origin of the motor nerves of the eye.
(05 Mar 2000)
nuclear Overhauser effect <enzyme> An enzyme seen in nuclear magnetic resonance in which there is a through-space nearest neighbor interaction.
(05 Mar 2000)
nuclear pacemaker A nuclear-powered unit used to generate the electrical current for artificially pacing the heart; replaced by units using long-life nickel-cadmium and other power sources.
(05 Mar 2000)
nuclear physician <specialist> A medically qualified specialist in internal medicine who has subspecialised in the use of radioactive materials for both the diagnosis and treatment of cancer and other conditions. The radioactive substances are normally injected intravenously but may be swallowed (for example radio-iodine). There are few such specialists and occasionally Radiation Oncologists also practise this!.
(16 Dec 1997)
nuclear pore <cell biology> Openings in the nuclear envelope, diameter about 10 nm, through which molecules such as nuclear proteins synthesised in the cytoplasm) and mRNA must pass. Pores are generated by a large protein assembly.
(18 Nov 1997)
nuclear proteins Proteins found in the nucleus of a cell. Do not confuse with nucleoproteins which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
(12 Dec 1998)
nuclear reaction The interaction of two atomic nuclei or of one such with a subatomic particle, or of the subatomic particles within an atomic nucleus, resulting in a change in the nature of the nuclei concerned or in the energy content of the nuclei or both, usually manifested by transmutation (accompanied by emission of alpha-, beta-, or gamma-rays) or by fission or fusion of the nuclei.
(05 Mar 2000)
nuclear reactors Devices containing fissionable material in sufficient quantity and so arranged as to be capable of maintaining a controlled, self-sustaining nuclear fission chain reaction. They are also known as atomic piles, atomic reactors, fission reactors, and nuclear piles, although such names are deprecated.
(12 Dec 1998)
nuclear RNA <molecular biology> The nucleus contains RNA that has just been synthesised, but in addition there is some that seems not to be released or is only released after further processing, the heterogenous nuclear RNA (hnRNA) and small RNA molecules associated with protein to form small nuclear ribonucleoproteins.
(18 Nov 1997)
nuclear run off assay <investigation, procedure> Technique for determining which genes are being actively transcribed at a given moment in an experiment by extracting nuclear material and allowing transcription to continue, then analysing the resulting RNAs.
(18 Nov 1997)
nuclear sap The presumably fluid substance or gel of the nucleus in which stainable elements were believed to be suspended; much that was formerly considered to be karyolymph is now known to be euchromatin.
Synonym: nuclear hyaloplasm, nuclear sap, nucleochylema, nucleochyme.
Origin: karyo-+ L. Lympha, clear water
(05 Mar 2000)
nuclear scaffold serine protease <enzyme> Calcium-regulated serine protease which cleaves a subset of lamins a/c (intermediate filament proteins) to produce an ATP-binding protein; partial amino-terminal amino acid sequence given in first source
Registry number: EC 3.4.21.-
Synonym: ns protease
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á